Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction.
Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
The story of neuromyelitis optica continues to be written.
GM-CSF-Neuroantigen Fusion Proteins Reverse Experimental Autoimmune Encephalomyelitis and Mediate Tolerogenic Activity in Adjuvant-Primed Environments: Association with Inflammation-Dependent, Inhibitory Antigen Presentation.
Age-associated changes in rat immune system: Lessons learned from experimental autoimmune encephalomyelitis.
5-HT2 RECEPTORS FACILITATE JC POLYOMAVIRUS ENTRY.
Modulators of the Sphingosine 1-phosphate receptor 1.
Immune response to chemically modified proteome.
The Encephalitogenic, Human Myelin Oligodendrocyte Glycoprotein-Induced Antibody Repertoire Is Directed towards Multiple Epitopes in C57BL/6-Immunized Mice.
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis.
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.
Correction: Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis.
Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer's Disease, and Multiple Sclerosis.
The clinical overlap of multiple sclerosis and headache.
Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus.
What went wrong? The flawed concept of cerebrospinal venous insufficiency.
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.
[Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet"]
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells.
General Mathematical Ability Predicts PASAT Performance in MS Patients: Implications for Clinical Interpretation and Cognitive Reserve.
Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Does long term treatment with azathioprine predispose to malignancy and death in patients with systemic lupus erythematosus?
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.

Pages